Eton Pharmaceuticals (ETON) Capital Expenditures Growth (5y) (2024 - 2025)

Eton Pharmaceuticals (ETON) Capital Expenditures Growth (5y) (2024 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.06 Bn 87.19 Bn -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn
3 Zoetis 32.39 Bn 30.45 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.59 Bn 23.53 Bn 4.39 Bn
5 United Therapeutics 23.19 Bn 21.04 Bn 648.10 Mn
6 RedHill Biopharma 20.53 Bn 20.53 Bn -
7 Viatris 20.27 Bn 18.46 Bn 1.16 Bn
8 Neurocrine Biosciences 18.00 Bn 16.69 Bn 800.70 Mn
9 Elanco Animal Health 12.65 Bn 12.22 Bn 785.00 Mn
10 Eton Pharmaceuticals 1.17 Bn 1.14 Bn 13.10 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 2.18%
Sep 30, 2025 169.44%
Dec 31, 2024 -18.80%
Mar 31, 2024 -22.78%